Patents by Inventor Dennis R. Morrison
Dennis R. Morrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20010026812Abstract: Microcapsules prepared by encapsulating an aqueous solution of a protein, drug or other bioactive substance inside a semi-permeable membrane by are disclosed. The microcapsules are formed by interfacial coacervation under conditions where the shear forces are limited to 0-100 dynes/cm2 at the interface. By placing the microcapsules in a high osmotic dewatering solution, the protein solution is gradually made saturated and then supersaturated, and the controlled nucleation and crystallization of the protein is achieved. The crystal-filled microcapsules prepared by this method can be conveniently harvested and stored while keeping the encapsulated crystals in essentially pristine condition due to the rugged, protective membrane. Because the membrane components themselves are x-ray transparent, large crystal-containing microcapsules can be individually selected, mounted in x-ray capillary tubes and subjected to high energy x-ray diffraction studies to determine the 3-D structure of the protein molecules.Type: ApplicationFiled: January 26, 2001Publication date: October 4, 2001Applicant: Government of the United States of America, National Aeronautics & Space AdministrationInventors: Dennis R. Morrison, Benjamin Mosier
-
Publication number: 20010006679Abstract: Microcapsules prepared by encapsulating an aqueous solution of a protein, drug or other bioactive substance inside a semi-permeable membrane by are disclosed. The microcapsules are formed by interfacial coacervation under conditions where the shear forces are limited to 0-100 dynes/cm2 at the interface. By placing the microcapsules in a high osmotic dewatering solution, the protein solution is gradually made saturated and then supersaturated, and the controlled nucleation and crystallization of the protein is achieved. The crystal-filled microcapsules prepared by this method can be conveniently harvested and stored while keeping the encapsulated crystals in essentially pristine condition due to the rugged, protective membrane. Because the membrane components themselves are x-ray transparent, large crystal-containing microcapsules can be individually selected, mounted in x-ray capillary tubes and subjected to high energy x-ray diffraction studies to determine the 3-D structure of the protein molecules.Type: ApplicationFiled: January 24, 2001Publication date: July 5, 2001Applicant: National Aeronautics & Space AdministrationInventors: Dennis R. Morrison, Benjamin Mosier
-
Publication number: 20010002261Abstract: Microcapsules prepared by encapsulating an aqueous solution of a protein, drug or other bioactive substance inside a semi-permeable membrane by are disclosed. The microcapsules are formed by interfacial coacervation under conditions where the shear forces are limited to 0-100 dynes/cm2 at the interface. By placing the microcapsules in a high osmotic dewatering solution, the protein solution is gradually made saturated and then supersaturated, and the controlled nucleation and crystallization of the protein is achieved. The crystal-filled microcapsules prepared by this method can be conveniently harvested and stored while keeping the encapsulated crystals in essentially pristine condition due to the rugged, protective membrane. Because the membrane components themselves are x-ray transparent, large crystal-containing microcapsules can be individually selected, mounted in x-ray capillary tubes and subjected to high energy x-ray diffraction studies to determine the 3-D structure of the protein molecules.Type: ApplicationFiled: December 6, 2000Publication date: May 31, 2001Applicant: Government of the United States of America National Aeronautics & Space AdministrationInventors: Dennis R. Morrison, Benjamin Mosier
-
Patent number: 6214300Abstract: A microencapsulation and electrostatic processing (MEP) device is provided for forming microcapsules. In one embodiment, the device comprises a chamber having a filter which separates a first region in the chamber from a second region in the chamber. An aqueous solution is introduced into the first region through an inlet port, and a hydrocarbon/polymer solution is introduced into the second region through another inlet port. The filter acts to stabilize the interface and suppress mixing between the two immiscible solutions as they are being introduced into their respective regions. After the solutions have been introduced and have become quiescent, the interface is gently separated from the filter. At this point, spontaneous formation of microcapsules at the interface may begin to occur, or some fluid motion may be provided to induce microcapsule formation. In any case, the fluid shear force at the interface is limited to less than 100 dynes/cm2.Type: GrantFiled: May 15, 1998Date of Patent: April 10, 2001Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space AdministrationInventors: Dennis R. Morrison, Benjamin Mosier, John M. Cassanto
-
Patent number: 6103271Abstract: Methods are provided for forming spherical multilamellar microcapsules having alternating hydrophilic and hydrophobic liquid layers, surrounded by flexible, semi-permeable hydrophobic or hydrophilic outer membranes which can be tailored specifically to control the diffusion rate. The methods of the invention rely on low shear mixing and liquid-liquid diffusion process and are particularly well suited for forming microcapsules containing both hydrophilic and hydrophobic drugs. These methods can be carried out in the absence of gravity and do not rely on density-driven phase separation, mechanical mixing or solvent evaporation phases. The methods include the process of forming, washing and filtering microcapsules. In addition, the methods contemplate coating microcapsules with ancillary coatings using an electrostatic field and free fluid electrophoresis of the microcapsules. The microcapsules produced by such methods are particularly useful in the delivery of pharmaceutical compositions.Type: GrantFiled: May 15, 1998Date of Patent: August 15, 2000Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space AdministrationInventors: Dennis R. Morrison, Benjamin Mosier
-
Patent number: 6099864Abstract: Disclosed are microcapsules comprising a polymer shell enclosing two or more immiscible liquid phases in which a drug, or a prodrug and a drug activator are partitioned into separate phases, or prevented from diffusing out of the microcapsule by a liquid phase in which the drug is poorly soluble. Also disclosed are methods of using the microcapsules for in situ activation of drugs, where upon exposure to an appropriate energy source the internal phases mix and the drug is activated in situ.Type: GrantFiled: May 15, 1998Date of Patent: August 8, 2000Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space AdministrationInventors: Dennis R. Morrison, Benjamin Mosier
-
Patent number: 5869238Abstract: The metastatic potential of tumors can be evaluated by the quantitative detection of urokinase and DNA. The cell sample selected for examination is analyzed for the presence of high levels of urokinase and abnormal DNA using analytical flow cytometry and digital image analysis. Other factors such as membrane associated urokinase, increased DNA synthesis rates and certain receptors can be used in the method for detection of potentially invasive tumors.Type: GrantFiled: February 16, 1995Date of Patent: February 9, 1999Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space AdministrationInventor: Dennis R. Morrison
-
Patent number: 5827531Abstract: Methods of forming multi-lamellar microcapsules having alternating layers of hydrophilic and hydrophobic immiscible liquid phases have been developed using different polymer/solvent systems. The methods use liquid-liquid diffusion and simultaneous lateral phase separation, controlled by proper timed-sequence exposures of immiscible phases and low shear mixing, to form narrow size distributions of spherical, multilamellar microcapsules. The use of special formulations of solubilized drugs, surfactants, and polymeric co-surfactants in aqueous vehicles which are dispersed in hydrocarbon solvents containing small quantities of oil, low molecular weight co-surfactants and glycerides that are aqueous insoluble enables the formation of unique microcapsules which can carry large amounts of pharmaceuticals in both aqueous and non-aqueous solvent compartments.Type: GrantFiled: December 2, 1994Date of Patent: October 27, 1998Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space AdministrationInventors: Dennis R. Morrison, Benjamin Mosier
-
Patent number: 5002890Abstract: A spiral vane bioreactor of a perfusion type in which a vertical chamber (10), intended for use in a microgravity condition, has a central rotating filter assembly (30) and has flexible membranes (56) disposed to rotate annularly about the filter assembly. The flexible members have end portions disposed angularly with respect to one another. A fluid replenishment medium is input (68) from a closed loop liquid system to a completely liquid filled chamber containing microcarrier beads, cells and a fluid medium. Output (36) of spent medium is to the closed loop. In the closed loop, the output and input parameters are sensed by sensors (82,96); a manifold 86 permits recharging of the nutrients and pH adjustment; oxygen is supplied and carbon dioxide removed, bubbles are removed and the system is monitored and controlled by a microprocessor (100).Type: GrantFiled: November 29, 1988Date of Patent: March 26, 1991Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space AdministrationInventor: Dennis R. Morrison
-
Patent number: 4235600Abstract: Garments are deposited in a cleaning drum and the drum is agitated during a wash cycle. A dry cleaning solvent is continuously added to the drum during the wash cycle and continuously removed from the drum during the wash cycle to flush the radioactive particulate material separated from the garments into a sump. The solvent is pumped from the sump for addition to the drum during the wash cycle and the pumped solvent is filtered to remove substantially all of the radioactive particulate material suspended in the solvent.The apparatus for decontaminating the radioactive garments comprises a sump for supporting a dry cleaning solvent. A drum for supporting the radioactively contaminated garments during a wash cycle which separates the radioactive particulate material from the garments means are provided for continuously pumping the dry cleaning solvent from the sump to the drum and for continuously removing the solvent and separated particulate material from the drum into the sump.Type: GrantFiled: November 9, 1978Date of Patent: November 25, 1980Assignee: Health Physics Systems, Inc.Inventors: Joseph A. Capella, Dennis R. Morrison